Invention Grant
- Patent Title: Use of toll-like receptor agonist for treating cancer
-
Application No.: US16279457Application Date: 2019-02-19
-
Publication No.: US10780152B2Publication Date: 2020-09-22
- Inventor: Anatoli Gleiberman , Lyudmila Burdelya , Andrei Gudkov
- Applicant: Cleveland BioLabs, Inc.
- Applicant Address: US NY Buffalo
- Assignee: Cleveland BioLabs, Inc.
- Current Assignee: Cleveland BioLabs, Inc.
- Current Assignee Address: US NY Buffalo
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07K14/195
- IPC: C07K14/195 ; C07K14/255 ; A61K38/16 ; A61K39/02 ; A61K39/112 ; A61K39/00 ; A61K39/395 ; C07K16/28 ; C07K14/705
Abstract:
The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
Public/Granted literature
- US20190275128A1 USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER Public/Granted day:2019-09-12
Information query
